Clinical Trial Update: BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravesical Botox (onabotulinumtoxinA) for overactive bladder with urinary incontinence has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Urinary Incontinence, Overactive Bladder With Urinary Incontinence | Phase 2 | Status: COMPLETED | Results posted: 2021-08-13